Max O'Donnell

Top grants by award amount

Max O'Donnell's NIH grant portfolio, ranked by award amount.

• 5R01AI176407-02R01

  Rapid phenotypic detection of complex and emergent TB drug-resistance using a next-generation nanoluciferase reporter phage

  Columbia University
  $746K

  award amount
• 5R01AI114900-10R01

  Advanced Genotypic and Phenotypic monitoring of Drug Resistant TB to Improve TB Treatment Outcomes

  Albert Einstein College of Medicine
  $723.3K

  award amount
• 5R01AI167795-03R01

  Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa

  Columbia University
  $566.5K

  award amount
• 5R21AI168940-02R21

  Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents

  Columbia University
  $179.3K

  award amount

Affiliations

Institutions that have administered grants for Max O'Donnell.

Career milestones

Key NIH funding milestones over time.

1. 2024
   First NIH Award
   Columbia University
2. 2024
   $500K Cumulative Funding
3. 2024
   $1M Cumulative Funding
4. 2024
   $2M Cumulative Funding
5. 2024
   Entered Top 50% Nationally
   Ranked #4464
6. 2024
   Entered Top 25% Nationally
   Ranked #4464
7. 2024
   Multi-Institutional Research
   Awards at 2 institutions

Related investigators

Other NIH-funded PIs frequently associated with Max O'Donnell.